Schroders Capital Global Innovation Trust PLC on Friday said it had made an investment of USD1.6 million in California-based clinical-stage cell therapy company Neurona Therapeutics.
The London-based.
Schroders Capital Global Innovation Trust announced an investment of $1.6m (£1.3m) in Neurona Therapeutics, a prominent US-based clinical-stage cell therapy company, on Friday.